Female Fertility: The Evidence-Based Supplement Protocol

← Back to articles

Fertility is dominated by age, ovarian reserve, tubal patency, sperm quality (partner), and underlying conditions like PCOS or endometriosis. Reproductive medicine — ovulation induction, IUI, IVF — remains the strongest intervention path for diagnosed infertility. Supplements have a defined role addressing preconception nutrient adequacy, oocyte quality in adults of advanced maternal age, and the metabolic features of PCOS.

Folate (5-MTHF or Folic Acid), 800–1,000 mcg Daily

Periconceptional folate at ≥400 mcg daily reduces neural tube defect risk by 50–70% — the strongest evidence-based supplement intervention in reproductive medicine. For women with MTHFR polymorphisms (~30% of population), L-methylfolate (5-MTHF or Quatrefolic) is preferred. Start 1–3 months before attempting conception. See our MTHFR fertility piece.

CoQ10 (Ubiquinol), 200–600 mg Daily — Especially Over 35

CoQ10 levels decline with age in ovarian mitochondria. Multiple trials have shown improved oocyte quality, fertilization rate, and embryo quality at 200–600 mg ubiquinol daily for 60–90 days before IVF in women over 35. Effect smaller in younger women. See CoQ10 form piece.

Vitamin D — Repletion to 30–50 ng/mL

Vitamin D deficiency is associated with reduced IVF success in cohort data. The 2020 RCT in 305 women undergoing IVF showed vitamin D repletion improved clinical pregnancy rate versus placebo in starting-deficient subgroups. Replete to target serum 25-OH-D. See vitamin D piece.

Myo-Inositol + D-Chiro Inositol (40:1) for PCOS-Related Infertility

For women with PCOS-related anovulatory infertility, myo-inositol 2 g + D-chiro inositol 50 mg twice daily restores ovulation in 60–70% of treated women versus 20–30% in placebo, with reduced free androgens and improved oocyte quality. See PCOS stack.

DHEA, 75 mg Daily — Diminished Ovarian Reserve Only

For women with diminished ovarian reserve, DHEA 25 mg three times daily for 60–90 days before IVF has shown improvements in antral follicle count and oocyte yield in multiple trials. Use only under reproductive endocrinology supervision — DHEA converts to androgens with potential side effects (acne, hirsutism). Not appropriate for women with normal reserve or PCOS.

What NOT to Take

Avoid herbal "fertility blends" with vitex (chasteberry) without RE input — it can interact with ovulation induction. Skip high-dose vitamin A and avoid retinol-based supplements in conception/early pregnancy — teratogenic risk. Avoid kava, St. John's Wort, ginkgo, and high-dose ginseng in the conception window. Avoid liver products in early pregnancy due to vitamin A content. See pregnancy supplement list.

How to Run the Protocol

Start prenatal vitamin (with ≥400 mcg methylfolate) 1–3 months before attempting conception. Test and replete vitamin D. For women over 35 or planning IVF: add CoQ10 ubiquinol 300–600 mg daily for 60–90 days. For PCOS: add inositol combination. For diminished reserve: DHEA only under RE supervision. The dominant factor in female fertility remains age — supplements modulate at the margins. See female fertility condition page.